GZ17‐6.02 initiates DNA damage causing autophagosome‐dependent HDAC degradation resulting in enhanced anti‐PD1 checkpoint inhibitory antibody efficacy
Author:
Affiliation:
1. Department of Biochemistry and Molecular Biology Virginia Commonwealth University Richmond Virginia
2. Genzada Pharmaceuticals Sterling Kansas
3. Translational Genomics Research Institute (TGEN) Phoenix Arizona
Funder
Genzada Pharmaceuticals
Commonwealth Health Research Board
Publisher
Wiley
Subject
Cell Biology,Clinical Biochemistry,Physiology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcp.29464
Reference46 articles.
1. Complementary and alternative medicine use among cancer patients in Palestine with special reference to safety-related concerns
2. Randomized Pharmacokinetic Crossover Study Comparing 2 Curcumin Preparations in Plasma and Rectal Tissue of Healthy Human Volunteers
3. A Controlled Study of a Lecithinized Delivery System of Curcumin (Meriva®) to Alleviate the Adverse Effects of Cancer Treatment
4. Genotoxic and recombinogenic activities of the two beta‐carboline alkaloids harman and harmine in Saccharomyces cerevisiae;Boeira J. M.;Mutation Research/DNA Repair,2002
5. [pemetrexed + sildenafil], via autophagy-dependent HDAC downregulation, enhances the immunotherapy response of NSCLC cells
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. GZ17-6.02 kills PDX isolates of uveal melanoma;Oncotarget;2024-05-17
2. GZ17-6.02 interacts with proteasome inhibitors to kill multiple myeloma cells;Oncotarget;2024-03-05
3. Immune checkpoints between epithelial-mesenchymal transition and autophagy: A conflicting triangle;Cancer Letters;2024-03
4. GZ17-6.02 interacts with bexarotene to kill mycosis fungoides cells;Oncotarget;2024-02-08
5. Pioglitazone treatment increases the cellular acid-labile and protein-bound sulfane sulfur fractions;Biochemical and Biophysical Research Communications;2023-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3